BioCentury
ARTICLE | Company News

Allergan, Lyndra in AD formulation deal

November 2, 2017 5:13 AM UTC

Allergan plc (NYSE:AGN) and Lyndra Inc. (Watertown, Mass.) partnered to develop once-weekly, oral formulations of Allergan’s treatments for Alzheimer’s disease. Allergan may also add another candidat...